Medicines

Two pivotal studies pave the way for tofacitinib (Xeljanz) in PsA: expert

Thursday, 17 Oct 2019


In this short video Professor Oliver FitzGerald from the University College Dublin, Ireland, discusses the findings of two pivotal studies on the use of tofacitinib (Xeljanz) in patients with psoriatic arthritis.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic